본문 바로가기 사이드메뉴 바로가기 주메뉴 바로가기

Media Center

A multimedia mosaic of moments at GIST

GIST Excellence

GIST, First-in-class immune anticancer drug GENA-104 function elucidated; New target CNTN4 overexpressed in cancer cells confirmed; Expected to develop new drug to treat patients who do not respond to existing immune anticancer drugs

  • 국제교류팀
  • REG_DATE : 2024.10.14
  • HIT : 28